Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

400
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
400
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

916
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
916
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

311
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
311
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

744
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
744
Statgraphics01:10

Statgraphics

487
Statgraphics is a comprehensive statistical software suite designed for both basic and advanced data analysis. Originating in 1980 at Princeton University under Dr. Neil W. Polhemus, it was one of the pioneering tools for statistical computing on personal computers, with its public release in 1982 marking an early milestone in data science software. Over the years, it has evolved into a robust platform for data science, offering tools for regression analysis, ANOVA, multivariate statistics,...
487
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters00:54

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

542
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
542

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ERRATUM: Cloud Computing for Pharmacometrics: Using AWS, NONMEM, PsN, Grid Engine, and Sonic.

CPT: pharmacometrics & systems pharmacology·2018
Same author

Reporting of vertebral fragility fractures: can radiologists help reduce the number of hip fractures?

Archives of osteoporosis·2017
Same author

AMPK promotes tolerance to Ras pathway inhibition by activating autophagy.

Oncogene·2016
Same author

[Thyrostimulation and sexual repose after the destruction of the epiphyseal region in Emys leprosa Schw].

Comptes rendus des seances de la Societe de biologie et de ses filiales·2014
Same author

Anaphylactic shock and serum cholinesterase.

La Presse medicale·2010
Same author

Influence of parenteral treatments on cholinesterase in ulcers.

Gastroenterologia·2010
Same journal

Optimizing Clinical Study Designs for CAR-T Cell Therapy: Development of an Efficient Sampling Strategy Through Optimal Experimental Design.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Integrated Population Pharmacokinetic Analysis of Intravitreal Aflibercept Drug Products.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Development and Use of a Population Pharmacokinetic Model for Characterizing the Pharmacokinetics of Vonoprazan in Pediatric Patients.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

A Narrative Review of Artificial Intelligence for Drug Repurposing: Lessons From COVID-19 and Oncology (2020-2025).

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Butorphanol Pharmacokinetics Across Species: Meta-Analysis Integrating Allometric Scaling and Minimal Physiologically Based Pharmacokinetic Modeling.

CPT: pharmacometrics & systems pharmacology·2026
See all related articles

Related Experiment Video

Updated: Apr 1, 2026

Author Spotlight: Enhancing Cryo-Electron Microscopy by Automated Data Collection and Analysis Techniques
07:52

Author Spotlight: Enhancing Cryo-Electron Microscopy by Automated Data Collection and Analysis Techniques

Published on: December 1, 2023

1.6K

Cloud Computing for Pharmacometrics: Using AWS, NONMEM, PsN, Grid Engine, and Sonic.

S Sanduja1, P Jewell1, E Aron1

  • 1Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, University of Florida Orlando, Florida, USA.

CPT: Pharmacometrics & Systems Pharmacology
|October 10, 2015
PubMed
Summary
This summary is machine-generated.

Build your own cloud computing cluster for faster pharmacometric analysis. This tutorial guides you through using Amazon Web Services (AWS) and specialized software for efficient research and reporting.

More Related Videos

gP2S, an Information Management System for CryoEM Experiments
13:01

gP2S, an Information Management System for CryoEM Experiments

Published on: June 10, 2021

6.0K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K

Related Experiment Videos

Last Updated: Apr 1, 2026

Author Spotlight: Enhancing Cryo-Electron Microscopy by Automated Data Collection and Analysis Techniques
07:52

Author Spotlight: Enhancing Cryo-Electron Microscopy by Automated Data Collection and Analysis Techniques

Published on: December 1, 2023

1.6K
gP2S, an Information Management System for CryoEM Experiments
13:01

gP2S, an Information Management System for CryoEM Experiments

Published on: June 10, 2021

6.0K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K

Area of Science:

  • Pharmacometrics
  • Computational Science
  • Scientific Computing

Background:

  • Traditional local data centers present challenges in resource accessibility and setup time for pharmacometric analyses.
  • Cloud computing offers scalable hardware, network, and security resources, enabling expedited analysis and reporting.
  • Cloud-based environments can be deployed more rapidly and with less effort than on-premises solutions.

Purpose of the Study:

  • To provide a practical tutorial for pharmacometricians on establishing a personal cloud computing cluster.
  • To demonstrate the integration of Amazon Web Services (AWS) with essential pharmacometric software.
  • To facilitate faster and more efficient data analysis and reporting in pharmacometrics.

Main Methods:

  • Utilizing Amazon Web Services (AWS) for cloud infrastructure.
  • Implementing NONMEM for pharmacokinetic/pharmacodynamic (PK/PD) modeling.
  • Leveraging PsN ( a Perl script interface for NONMEM) for workflow automation.
  • Configuring Grid Engine for job scheduling.
  • Integrating Sonic for cluster management and communication.

Main Results:

  • A functional personal cloud computer cluster tailored for pharmacometric tasks can be successfully built.
  • The setup process is detailed, enabling users to replicate the environment.
  • The resulting cluster expedites analysis and reporting compared to traditional methods.

Conclusions:

  • Cloud computing, specifically using AWS, provides an accessible and efficient platform for pharmacometricians.
  • Building a personal cloud cluster with NONMEM, PsN, Grid Engine, and Sonic is feasible and beneficial.
  • This approach significantly reduces the time and effort required for complex analyses and reporting in pharmacometrics.